Scientists have experimented with mRNA for decades, but the pandemic foisted the platform into the limelight. The Pfizer-BioNTech (NYSE:PFE/NSDQ:BNTX) and Moderna (NSDQ:MRNA) COVID-19 vaccines have since emerged as two of the best-selling pharmaceutical products in recent memory.
Researchers are now exploring dozens of new possibilities for the mRNA platform.
Here, we summarize several areas where mRNA could find use in the coming years.
Get the full story from our sister site, Drug Discovery & Development.